Nina Capital launches €50M fund for early-stage healthtech

Healthtech investor Nina Capital has announced the first close of its €50M Fund III. Contributors to the fund include Boston-based wealth management firm Seven Two Partners, professional family offices, foundations, corporations, and individuals across Europe and the United States.

"Healthcare is at the forefront of a transformative era, where groundbreaking innovations are creating immense opportunities for both patient impact and investors," said Andrew Macken, Managing Partner at Seven Two. "For the best outcomes in this complex industry, we believe that it is important for managers to find great founders who are working on solving these significant problems and for those managers to help these businesses grow. We are impressed with the work that Marta and her team have accomplished and excited to see what Nina Capital has in store to reshape the future of healthcare.”

With Fund III, Nina Capital plans to establish a new investment portfolio spanning Europe, North America, Israel, and, for the first time, Australia. Investments will span from pre-seed to Series A with initial checks ranging from €250,000 to €1.5M and reserves to support portfolio companies through follow-on funding.

The firm has already made its first Fund III investment: Sonar Mental Health, a US-based mental health platform  that assists students through a combination of AI and human-led support. It plans two more investment in early 2025.

"Healthcare is at the forefront of a transformative era, where groundbreaking innovations are creating immense opportunities for both patient impact and investors," said Andrew Macken, Managing Partner at Seven Two.

"For the best outcomes in this complex industry, we believe that it is important for managers to find great founders who are working on solving these significant problems and for those managers to help these businesses grow. We are impressed with the work that Marta and her team have accomplished and excited to see what Nina Capital has in store to reshape the future of healthcare.”